公司概覽
業務類別 Biotechnology
業務概覽 ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.
公司地址 11682 El Camino Real, Suite 120, San Diego, CA, USA, 92130
電話號碼 +1 858 771-9307
傳真號碼 --
公司網頁 https://www.ars-pharma.com
員工數量 160
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Alexander A. Fitzpatrick, J.D. Chief Legal Officer and Secretary -- 29/04/2025
Ms. Kathleen D. Scott Chief Financial Officer and Principal Accounting Officer -- 29/04/2025
Mr. Justin Chakma Chief Business Officer -- 29/04/2025
Mr. Eric Karas Chief Commercial Officer -- 29/04/2025
Dr. Sarina Tanimoto, M.B.A.,M.D. Chief Medical Officer 美元 501.70K 29/04/2025
Mr. Richard E. Lowenthal, M.B.A.,M.S. President, Chief Executive Officer and Director 美元 651.00K 29/04/2025
Mr. Brian T. Dorsey, M. Sc. Chief Operating Officer 美元 451.00K 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Brenton L. Saunders Director 29/04/2025
Dr. Peter A. Thompson,M.D.,F.A.C.P. Independent Director 29/04/2025
Dr. Peter Kolchinsky, PhD Independent Director 29/04/2025
Dr. Rajeev Dadoo, PhD Independent Director 29/04/2025
Mr. Michael Kelly Independent Director 29/04/2025
Dr. Laura Shawver, PhD Director 29/04/2025
Mr. Saqib Islam, J.D. Independent Director 29/04/2025
Mr. Richard E. Lowenthal, M.B.A.,M.S. President, Chief Executive Officer and Director 29/04/2025
Dr. Pratik Shah, PhD Chairman of the Board 29/04/2025
Mr. Phillip M. Schneider Independent Director 29/04/2025
 
所屬ETF (更新日期: 07/03/2026 04:00)
代號 名稱 佔比% 持有日期
FHLCFidelity MSCI Health Care ETF0.02%28/02/2026
SYZLazard US Systematic Small Cap Eq ETF0.01%28/02/2026
AVTMAvantis Total Equity Markets ETF0.01%28/02/2026
DFACDimensional US Core Equity 2 ETF0.01%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.01%27/02/2026
GRXGabelli Health & Wellness0.01%31/12/2025
OMFSInvesco Russell 2000® Dynamic Mltfct ETF0.005%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.005%27/02/2026
VTHRVanguard Russell 3000 ETF0.005%31/01/2026
WSMLiShares MSCI World Small-Cap ETF0.004%28/02/2026
UWMProShares Ultra Russell20000.004%27/02/2026
URTYProShares UltraPro Russell20000.004%27/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF0.003%28/02/2026
ITWOProShares Russell 2000 High Income ETF0.003%27/02/2026
TILTFlexShares Mstar US Mkt Factors Tilt ETF0.003%27/02/2026
SPGMState Street® SPDR® Ptf MSCIGlbStkMktETF0.002%27/02/2026
RFLRInnovator U.S. Small Cp Mgd Flr ETF0.002%25/02/2026
ESSCEventide Small Cap ETF0.001%27/02/2026
DFAUDimensional US Core Equity Market ETF0.001%27/02/2026
DCORDimensional US Core Equity 1 ETF0.001%27/02/2026
  1   2    3  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.